[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365959-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365959-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integrated-tumour-immune-cell-response-modelling-of-luminal-a-breast-cancer-details-malignant-signalling-and-st3gal1-inhibitor-induced-reversal","Integrated tumour-immune cell response modelling of luminal a breast cancer - details malignant signalling and ST3Gal1 inhibitor-induced reversal","","Aberrant O-glycosylation of MUC1 drives immune modulation that supports tumour growth and metastasis, yet system-level links between MUC1 O-glycosylation and immune cells remain insufficiently modelled. A three-part ordinary differential equations systems model was developed, coupling tumour-cell MUC1-type O-glycosylation, macrophage chemokine secretion, and tumour-cell signal transduction. Comparative CytoCopasi simulations showed that LuminalA upregulation of MUC1 sialyl-T antigen increases CXCL5 in tumour-associated macrophages, creating positive feedback via signal transduction and autocrine CXCL5. Perturbing the glycosylation network using the ST3Gal1 inhibitor Soyasaponin-I abolished the downstream malignant upregulations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrated-tumour-immune-cell-response-modelling-of-luminal-a-breast-cancer-details-malignant-signalling-and-st3gal1-inhibitor-induced-reversal/365959/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrated-tumour-immune-cell-response-modelling-of-luminal-a-breast-cancer-details-malignant-signalling-and-st3gal1-inhibitor-induced-reversal/365959.png","ImageObject",300,407,{"name":42,"@type":43},"นรินทร์","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is MUC1 aberrant O-glycosylation important in breast cancer immune modulation?","Question",{"text":63,"@type":64},"Aberrant MUC1 O-glycosylation is implicated in cancer processes that manipulate immune responses to favour tumour growth and metastasis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What are the three component models in the constructed systems model?",{"text":68,"@type":64},"The model combines (1) MUC1-type O-glycosylation in tumour cells, (2) chemokine secretion in macrophages, and (3) signal transduction in tumour cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What effect does Soyasaponin-I have in the modelling results?",{"text":72,"@type":64},"Perturbing the glycosylation network with the sialyltransferase inhibitor Soyasaponin-I abrogated the cancerous upregulations in the downstream networks.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365959,1790197752,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","Integrated tumour-immune cell response modelling of luminal a breast cancer details malignant signalling and ST3Gal1 inhibitor-induced reversal  \nHikmet Emre Kaya1 ,2 , Kevin J. Naidoo1 ,2 , *   \n1 Scientiﬁc Computing Research Unit Address, PD Hahn Building, University of Cape Town, Rondebosch 7701, South Africa, 2 Department of Chemistry, PD Hahn Building, University of Cape Town, Rondebosch 7701, South Africa  \n*Corresponding author. Scientiﬁc Computing Research Unit Address, PD Hahn Building, University of Cape Town, Rondebosch 7701, South Africa. Email: [kevin.naidoo@uct.ac.za](kevin.naidoo@uct.ac.za).  \nAberrant O-glycosylation of mucin-type glycopeptide 1 (MUC1) is implicated in cancerous cellular processes involving the manipulation of immune response to favour tumour growth and metastasis. There is an unmet need for systems glycobiology models to probe the relationship between MUC1 O-glycosylation and immune cells within the tumour microenvironment. We expand on the sparsely understood MUC1 and immune cell interactions by building a complete systems model that combines the glycosylation network in the tumour cell with downstream biological networks. An ordinary differential equations-based model of the effect of aberrant glycosylation on immune modulation in breast cancer was constructed. The model comprises three interdependent component models that are MUC1-type O-glycosylation in the tumour cell, chemokine secretion in macrophages, and signal transduction in the tumour cells. A comparative CytoCopasi algorithm was developed to sequentially perturb the networks by an aberrant O-glycosylation. Comparative simulations revealed that upregulation of tumour-associated MUC1 sialyl-T antigen in LuminalA breast cancer stimulated the upregulation of the chemokine CXCL5 in tumour-associated macrophages. Consequently, increased CXCL5 binding by the tumour cell led to a positive feedback loop through overactive signal transduction and autocrine CXCL5 production. Finally, perturbing the glycosylation network with the sialyltransferase inhibitor Soyasaponin-I abrogated the cancerous upregulations in the downstream networks.  \nKeywords: aberrant glycosylation; breast cancer; immune modulation; systems biology.  \nIntroduction  \nEpithelial cells play a central role in fending off disease introduced by pathogens as the first line of defence against microorganism invasion. Glycoconjugates such as mucins area primary component of this defence mechanism (Lindén et al. 2009; Boll et al. 2017) . In epithelial cancers, the biochemical and molecular defence networks against diseases are altered in these cells to facilitate their transition toward tumour cells. Of particular relevance are the alterations in glycoconjugates where the resultant aberrant glycosylation(s) is significantly associated with poor prognosis and malignancy in cancer (Meany and Chan 2011; Bangarh et al. 2023) .  \nSialyltransferases such as ST3 beta-galactoside α-2,3-Sialyltransferase 1 (ST3Gal1) have been identified as possible targets in cancer care (Burchell et al. 1999). On the other hand, glycosyltransferase inhibitor discovery has been hampered by a lack of structural and mechanistic data to guide the design process (Gloster and Vocadlo 2012; Bowles and Gloster 2021) . At the molecular scale, computational work schemes are developed to address this problem (Crous and Naidoo 2016; Senapathi et al. 2019; Senapathi et al. 2020) . Alongside this, a small number of potential inhibitors have been derived from soyasaponin I or triazole against the cancerassociated ST3Gal1 (Wu et al. 2001; Chang et al. 2006; Szabo  \net al. 2024) . Soyasaponin I- and lithocholic acid-derived inhibitors impeded invasion and migration capabilities in breast cancer cell lines (Hsu et al. 2005; Chen et al. 2011) . There is the caveat that these studies involved endpoint assays with substrate concentrations below saturation, yielding unrealistic IC50 values. A universal glycosyltransferase assay","cbCaiaSGEQuuGxhN","https://ap.wps.com/l/cbCaiaSGEQuuGxhN","pdf",1808546,14,"English","# Introduction\n## Tumour-associated MUC1 O-glycosylation and immune modulation\n## ST3Gal1 as a therapeutic target\n# Methods and Model Construction\n## ODE-based component models\n## CytoCopasi comparative network perturbations\n# Results and Biological Interpretation\n## CXCL5 induction and positive feedback signalling\n## Effects of Soyasaponin-I inhibition","[{\"question\":\"Why is MUC1 aberrant O-glycosylation important in breast cancer immune modulation?\",\"answer\":\"Aberrant MUC1 O-glycosylation is implicated in cancer processes that manipulate immune responses to favour tumour growth and metastasis.\"},{\"question\":\"What are the three component models in the constructed systems model?\",\"answer\":\"The model combines (1) MUC1-type O-glycosylation in tumour cells, (2) chemokine secretion in macrophages, and (3) signal transduction in tumour cells.\"},{\"question\":\"What effect does Soyasaponin-I have in the modelling results?\",\"answer\":\"Perturbing the glycosylation network with the sialyltransferase inhibitor Soyasaponin-I abrogated the cancerous upregulations in the downstream networks.\"}]","Integrated tumour-immune cell response modelling of luminal a breast cancer - details malignant signalling and ST3Gal1 inhibitor-induced reversal | PDF",1790163122,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee4f5de139a90e54e7b49b97349875b7.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/567943cb4ee39c702d3a3edb794ace4b.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bc9e32e5570e1cd4696abc40b665087.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d7a92d446ecbd2dbfbb502f03cfad46.webp",980,1287]